The Ministry of Health has registered a single-dose Johnson & Johnson vaccine
The Ministry of Health of Ukraine has registered the Janssen vaccine (by Johnson & Johnson) against COVID-19 for emergency medical use.
UA reports this citing the website of the Ministry of Health.
Janssen is a vector vaccine developed by Janssen, owned by Johnson & Johnson. The vaccine contains a neutralized human adenovirus, which is embedded with DNA encoding the Spike protein of the SARS-CoV-2 virus.
One dose is enough for complete immunization.
The vaccine is approved for emergency use by the World Health Organization, and has been approved by the United States, the United Kingdom, the European Union, Switzerland, Canada, and many other countries.
As of July 4, 244 cases of a coronavirus were registered in Ukraine. 333 people were hospitalized.